focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
I'd be really happy with the lowest analyst target, which appears to be 87p.....but I haven't held that long. I'll be VERY happy with £2. I guess it depends on the big shareholders and the company management what gets agreed or not.
Not been invested here for a while but it's going far worse than I imagined it would be by this point, for shareholders at least. I expected the management would have been able to get ahead of events a bit and execute a proper placing early in the year.
Crooty,
Fair point. Perhaps their strategy will be to raise about £2m at 2p and then come back and do another placing once FDA is granted.
It's been a slow, creeping dilution though Neil. At the beginning of last April there was 99 million shares in issue. Now there's 134 million!
But defining decent is tricky. If they raise £5m I would definitely buy in again. But would be very wary if it's only £2m.
If they can pull off a decent raise, it should go up quite quickly, initially at least....still a lot of interest from retail investors in this stock.
Interesting though in RENX's case the share price didn't actually fall to by 50%. It was only 20% down the day after the announcement as people bought in to take advantage of the cheaper shares....
Elephant in the room: what price do people think this upcoming equity placing is going to be at?
RENX recently did one (similar type of company to GDR in a lot of ways) and it was at a 50% discount. But not completely comparable as it already has FDA approval, though it has very high cash burn.........
If you ask me, best case for getting NICE approval is 2026 and best case for specialist commissioning route for NHS England is 2025 (but those timing estimations are conjecture/guesswork)
For NHS wide roll out you need full NICE approval (GDR are already in process but exact timing (and outcome obviously) is uncertain). But you can also go for an approval for NHS England through "specialist commissioning". GDR has mentioned the latter option in a presentation but we don't know if anything at all has actually happened on that. The specialist commissioning route can be a bit quicker apparently.
Approval at the local level is short answer.....(not using central NHS budget, technically at least)
Neil, Some hospitals in Manchester are using AIHL as well in routine use. Trouble is, GDR needs more than a handful. They need mass market penetration. It takes time to get their because some of the "approvals" you need are a bit nuanced. There's medical approval on one level and then on another, for example, but then there's getting your product on an NHS default buy list. It's similar in all European countries. In US you need FDA, but then you also need Medicaid coverage these days and then you need insurers to accept you as well. It can be a long road...
Crooty, Would say if they can raise the money, the big hope will be US commercialisation/FDA approval. Trouble is even with FDA approval, it can take a bit of time to get big orders. Just depends. Then you also have to win Medicaid coverage as well would guess.
That's unfair Gloria. Lol. It's possible there will be a placing at 0.25p, or even 1p. And then people can dream of it hitting 4p again.
Agree with Eureka, the RNS seems a bit odd. But guess it does clear up the fact that they have received the tax credit. They still planning a fund raise (and clarification that it's definitely an equity placing they trying to go for). Might be a chance for me to invest here again soon now, if they get the funding situation sorted. Though I'm a bit heavily committed elsewhere at the mo. Was hoping they would have got the placing sorted in February so could have invested quite a bit then.
When it was 0.3p, unfortunately I was a bit put off by someone warning it might not be a commercial find. But I was also fully invested somewhere else as well at that point, so would have had to sell that first.
I wasnt being serious Neil. The spread is awful. Good call on Helium One though at the beginning. I nearly put a lot it when it was 0.3p but was fully committed elsewhere so I waited. Ended up making easy £10k when it was at 2p though, as it kept going up to about 2.5p.
It just hit 5p and then fell sharply as Neil and his mates sold their trading shares. lol
Could be because RF have exhausted their share dump - simply no more to sell. Maybe we'll see another drawdown announced soon and the whole process starts afresh who knows.
It's an impressive list. I wonder what price they hoping to get for the business?